Cargando…

Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure

Although antiretroviral therapy (ART) can reduce the viral load in the plasma to undetectable levels in human immunodeficiency virus (HIV)-infected individuals, ART alone cannot completely eliminate HIV due to its integration into the host cell genome to form viral reservoirs. To achieve a functiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuang, Wang, Hu, Guo, Na, Su, Bin, Lambotte, Olivier, Zhang, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684145/ https://www.ncbi.nlm.nih.gov/pubmed/37927030 http://dx.doi.org/10.1097/CM9.0000000000002904

Ejemplares similares

Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir
por: Choudhary, Madhu C., et al.
Publicado: (2022)

HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
por: Li, Shuang, et al.
Publicado: (2022)

Targeting the Brain Reservoirs: Toward an HIV Cure
por: Marban, Céline, et al.
Publicado: (2016)

Targeting the latent reservoir to achieve functional HIV cure
por: Cary, Daniele C., et al.
Publicado: (2016)

Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays
por: Khetan, Priya, et al.
Publicado: (2022)

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure
por: Ash, Michelle K., et al.
Publicado: (2021)

Oral abstracts of the HIV Cure and Reservoir Symposium 2017
Publicado: (2017)

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
por: Denton, Paul W., et al.
Publicado: (2019)

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection
por: Bai, Ruojing, et al.
Publicado: (2022)

Block and Lock HIV Cure Strategies to Control the Latent Reservoir
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2020)

Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV
por: Urak, Ryan Z., et al.
Publicado: (2020)

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
por: Goonetilleke, Nilu, et al.
Publicado: (2019)

Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies
por: Woldemeskel, Bezawit A., et al.
Publicado: (2020)

Editorial: Exploring Novel Approaches to Eliminate HIV Reservoirs to Achieve a Cure for HIV
por: van der Sluis, Renée M., et al.
Publicado: (2021)

Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4(+) T cells to reduce the latent HIV(+) cell reservoir
por: Patasic, Lea, et al.
Publicado: (2020)

Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
por: Han, Xiao, et al.
Publicado: (2019)

Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023)

HIV-1 Infection and Glucose Metabolism Reprogramming of T Cells: Another Approach Toward Functional Cure and Reservoir Eradication
por: Kang, Shuang, et al.
Publicado: (2020)

HIV controllers: state of the art
por: Lambotte, Olivier
Publicado: (2010)

The reservoir of latent HIV
por: Chen, Jing, et al.
Publicado: (2022)

Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies
por: Buck, Amanda M., et al.
Publicado: (2023)

Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”
por: Jefferys, Richard J
Publicado: (2010)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
por: Staudt, Ross E, et al.
Publicado: (2022)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
por: Schorr, Christopher, et al.
Publicado: (2022)

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
por: Mensali, Nadia, et al.
Publicado: (2023)

Chimeric Antigen Receptor T Cell Therapy in Hematology
por: Ataca, Pınar, et al.
Publicado: (2015)

Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
por: Reinhardt, Bryanna, et al.
Publicado: (2023)

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
por: Uslu, Ugur, et al.
Publicado: (2023)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023)

HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites
por: Saksena, Nitin K, et al.
Publicado: (2010)

Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
por: Yan, Wenying, et al.
Publicado: (2019)

Chimeric non-antigen receptors in T cell-based cancer therapy
por: Guo, Jitao, et al.
Publicado: (2021)

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level
por: Canouï, Etienne, et al.
Publicado: (2017)

Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies
por: Guo, Zhenling, et al.
Publicado: (2021)

Biomarkers in individualized management of chimeric antigen receptor T cell therapy
por: Du, Mengyi, et al.
Publicado: (2020)

The Chimeric Antigen Receptor Detection Toolkit
por: Hu, Yifei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m0gajrsp8noj6mpcg4nbp6beu2